Literature DB >> 16564767

Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties.

Robert M Arnold1, Paul K J Han, Deborah Seltzer.   

Abstract

In this article, we review the principal objectives and ideal elements of opioid contracts, as articulated by proponents of the practice. We examine the limited empirical evidence for the effectiveness of opioid contracts in achieving their intended objectives and identify areas of uncertainty and of ethical concern regarding their implementation. We argue that the challenge in deciding about implementing opioid contracts in clinical practice relates to the multiplicity of potential objectives they might serve, to a lack of empirical evidence regarding their effectiveness, and to ethical concerns over their implementation. Specialty and primary care clinicians contemplating the use of opioid contracts in treating patients with chronic nonmalignant pain need to be sensitive to these considerations, and further debate and research is necessary to establish the proper objectives, elements, effectiveness, and ethical justifications of opioid contracts in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564767     DOI: 10.1016/j.amjmed.2005.09.019

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  23 in total

Review 1.  Pragmatic Opioid Use in Painful Diabetic Neuropathy.

Authors:  Yatan Pal Singh Balhara; Shalini Singh; Sanjay Kalra
Journal:  Eur Endocrinol       Date:  2020-02-04

2.  Capsule commentary on Turner et al., chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.

Authors:  Ben A Rich
Journal:  J Gen Intern Med       Date:  2014-02       Impact factor: 5.128

3.  Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Marco L A Sivilotti; Alex Kopp; Omar Qureshi; David N Juurlink
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

Review 4.  Informed consent in opioid therapy: a potential obligation and opportunity.

Authors:  Martin D Cheatle; Seddon R Savage
Journal:  J Pain Symptom Manage       Date:  2012-03-21       Impact factor: 3.612

5.  Opioids, pain and addiction - practical strategies.

Authors:  Roman D Jovey
Journal:  Br J Pain       Date:  2012-02

6.  Developing and Initiating Validation of a Model Opioid Patient-Prescriber Agreement as a Tool for Patient-Centered Pain Treatment.

Authors:  Mary P Ghods; Ian T Schmid; Carol A Pamer; Brian M Lappin; Dale C Slavin
Journal:  Patient       Date:  2015-08       Impact factor: 3.883

Review 7.  The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document.

Authors:  Barth Wilsey; J Hampton Atkinson; Thomas D Marcotte; Igor Grant
Journal:  Clin J Pain       Date:  2015-12       Impact factor: 3.442

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  A primary care-based interdisciplinary team approach to the treatment of chronic pain utilizing a pragmatic clinical trials framework.

Authors:  Lynn L Debar; Lindsay Kindler; Francis J Keefe; Carla A Green; David H Smith; Richard A Deyo; Katharine Ames; Adrianne Feldstein
Journal:  Transl Behav Med       Date:  2012-08-30       Impact factor: 3.046

10.  Perceptions of patient provider agreements.

Authors:  Jennifer S Albrecht; Bilal Khokhar; Françoise Pradel; Michelle Campbell; Jacqueline Palmer; Ilene Harris; Francis Palumbo
Journal:  J Pharm Health Serv Res       Date:  2015-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.